Craft

Sight Sciences

Stock Price

$5.3

2024-10-29

Market Capitalization

$265.1 M

2024-10-29

Revenue

$77.4 M

FY, 2025

Sight Sciences Summary

Company Summary

Overview
Sight Sciences is an ophthalmic medical device company that develops surgical and nonsurgical technologies for the treatment of eye diseases. Its products include OMNI Surgical System, a therapeutic device used to reduce intraocular pressure in adult glaucoma patients; and TearCare System, a wearable eyelid technology, for the treatment of dry eye disease (DED). The company caters to hospitals, medical centers, and eye care professionals.
Type
Public
Status
Active
Founded
2011
HQ
Menlo Park, CA, US | view all locations
Website
https://www.sightsciences.com
Cybersecurity rating
ESG rating
40-49 out of 100|View all ESG data
Sectors

Key People

  • Paul Badawi, Founder, Chief Executive Officer

    • David Badawi, Founder, Chief Technology Officer

      • Jesse Selnick

        Jesse Selnick, Chief Financial Officer

      • Sam Park

        Sam Park, Chief Operating Officer

      LocationsView all

      4 locations detected

      • Menlo Park, CA HQ

        United States

        4040 Campbell Ave #100

      • Southlake, TX

        United States

        141 Countryside Ct #140

      • Southlake, TX

        United States

        2141 E Kirkwood Blvd #130

      • London, England

        United Kingdom

        5 New St Square

      Sight Sciences Financials

      Summary Financials

      Revenue (Q1, 2026)
      $19.7M
      Gross profit (Q1, 2026)
      $17.0M
      Net income (Q1, 2026)
      ($13.0M)
      Cash (Q1, 2026)
      $85.0M
      EBIT (Q1, 2026)
      ($12.4M)
      Enterprise value
      $220.7M

      Footer menu